Is cyclic vomiting syndrome related to migraine?

B U Li1, R D Murray, L A Heitlinger

  • 1Department of Pediatrics, The Ohio State University, Columbus Children's Hospital, Columbus, Ohio, USA.

Insights

Most children with cyclic vomiting syndrome (CVS) also have migraine. Migraine-associated CVS in children presents with milder vomiting, more migraine symptoms, and better response to migraine treatments.

Area of Science:

  • Pediatric Gastroenterology
  • Neurology
  • Genetics

Background:

  • Cyclic vomiting syndrome (CVS) is a functional gastrointestinal disorder characterized by recurrent episodes of intense nausea and vomiting.
  • The relationship between CVS and migraine, particularly in pediatric populations, requires further elucidation.
  • Understanding this association can inform diagnosis and treatment strategies for children experiencing CVS.

Purpose of the Study:

  • To investigate the prevalence and clinical characteristics of migraine-associated CVS in children.
  • To compare pediatric patients with migraine-associated CVS to those with non-migraine-associated CVS.
  • To determine the impact of migraine association on episode severity and treatment response.

Main Methods:

  • A retrospective study of children under 18 diagnosed with CVS between 1986 and 1998.
  • Data collection through chart reviews and structured interviews to assess clinical patterns and treatment outcomes.
  • Classification of CVS into migraine-associated (based on family history or personal development of migraines) and non-migraine-associated subgroups.

Main Results:

  • 82% of 214 pediatric CVS patients had migraine-associated CVS.
  • Migraine-associated CVS subgroup experienced milder vomiting episodes (20.7 vs. 39.5 emeses/episode).
  • This subgroup also reported more symptoms like abdominal pain, headache, social withdrawal, photophobia, and responded better to anti-migraine therapy (79% vs. 36%).

Conclusions:

  • The majority of pediatric CVS cases are associated with migraine.
  • Migraine-associated CVS in children exhibits distinct clinical features, including less severe vomiting and migraine-like symptoms.
  • These findings reinforce the strong link between migraine and CVS, suggesting shared pathophysiology.
Abstract

Related Concept Videos

Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
Equilibrium and Balance01:15

Equilibrium and Balance

The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...